Conduction disease in IPAH: prevalence and clinical implications
A. Reddy (Cambridge, United Kingdom), S. Nethercott (Cambridge, United Kingdom), W. Teh (Cambridge, United Kingdom), E. De Bie (Cambridge, United Kingdom), J. Pepke-Zaba (Cambridge, United Kingdom), C. Martin (Cambridge, United Kingdom), M. Toshner (Cambridge, United Kingdom)
Source: International Congress 2022 – Diagnosis and epidemiology in pulmonary hypertension
Session: Diagnosis and epidemiology in pulmonary hypertension
Session type: Thematic Poster
Number: 1978
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Reddy (Cambridge, United Kingdom), S. Nethercott (Cambridge, United Kingdom), W. Teh (Cambridge, United Kingdom), E. De Bie (Cambridge, United Kingdom), J. Pepke-Zaba (Cambridge, United Kingdom), C. Martin (Cambridge, United Kingdom), M. Toshner (Cambridge, United Kingdom). Conduction disease in IPAH: prevalence and clinical implications. 1978
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|